Inamori Foundation Company Profile

07:47 EDT 1st July 2016 | BioPortfolio

The non-profit Inamori Foundation was established in 1984 by Dr. Kazuo Inamori, founder and chairman emeritus of Kyocera (NYSE:KYO) and KDDI Corporation. The Foundation created the Kyoto Prize in 1985, in line with Dr. Inamori’s belief that a human being has no higher calling than to strive for the greater good of society, and that the future of humanity can be assured only when there is a balance between our scientific progress and our spiritual depth. As of the 26th Kyoto Prize ceremony (November 10, 2010), the prize has been awarded to 84 individuals and one foundation — collectively representing 15 nations. Individual laureates range from scientists, engineers and researchers to philosophers, painters, architects, sculptors, musicians and film directors. The United States has produced the most recipients (34), followed by Japan (14), the United Kingdom (12), and France (8).

News Articles [540 Associated News Articles listed on BioPortfolio]

Inamori International Center selects Transparency International founder Peter Eigen

(Case Western Reserve University) The Inamori International Center for Ethics and Excellence at Case Western Reserve University has selected Peter Eigen, founder of Transparency International and pion...

The Ewing Marion Kauffman Foundation: Entrepreneurship and Success

In this interview, Lesa Mitchell, VP Kauffman Foundation, Ewing Marion Kauffman Foundation, talks to Dr Fintan Walton about: • the Foundation’s origins and its focus on entrepreneurship • its re...

Biophysics fights cancer

(National Science Foundation) Whether it focuses on determining why certain cancers develop drug resistance, finding a way to improve individual's immune systems or better understanding cancer cell ev...

Lex Mundi Pro Bono Foundation Marks Ten Years of Impact on Social Change Around the Globe

WASHINGTON, DC (PRWEB) March 15, 2016 In 2016, the Lex Mundi Pro Bono Foundation (Foundation) celebrates ten years of helping orga...

5 facts about the PhRMA Foundation

As the PhRMA Foundation celebrates its 50th year, here are five facts about the PhRMA Foundation and its work to support young pharmaceutical scientists across the United States. For youn...

NET Research Foundation receives transformational gift for rare cancer research

(Neuroendocrine Tumor Research Foundation) NET Research Foundation receives $15 million gift from the Margie and Robert E. Petersen Foundation to fund ambitious research effort to find cure for rare c...

Tax Foundation Analysis Of Sanders Plan Only Shows Downside

The Tax Foundation has scored the Bernie Sanders tax plan. As you might expect, it is not a pretty picture. I think that there is something of a flaw in the Tax Foundation's model in looking at whethe...

Medifast partners with Rutgers, V Foundation on new sports nutrition product line

Michael JohnsenA portion of sales from The V Foundation products will go directly back to the Foundation. For the Rutgers products, a portion of the proceeds will go to the R Fund. read more

Drugs and Medications [0 Results]


PubMed Articles [226 Associated PubMed Articles listed on BioPortfolio]

Meta-analysis of diabetes mellitus and risk of hip fractures: small-study effect.

Simulation training for foundation doctors on the management of the acutely ill patient.

A study evaluating subjective trainee responses to simulation training organized by the Malta Foundation Program in particular whether this changed their clinical practice.

Growth traits of four maternal lines of rabbits founded on different criteria: comparisons at foundation and at last periods after selection.

The objective was to compare growth traits in four maternal lines of rabbits (A, V, H and LP), with the aim of understanding the consequence of the different foundation and selection processes on the ...

Polycythemia is associated with bone loss and reduced osteoblast activity in mice.

Increased fragility has been described in humans with polycythemia vera (PV). Herein, we describe an osteoporotic phenotype associated with decreased osteoblast activity in a mouse model of PV and ano...

Management of hip fractures in older people in Beijing: a retrospective audit and comparison with evidence-based guidelines and practice in the UK.

Despite the high burden of hip fracture in China, there is limited information on its management. This study investigated the management of hip fractures in a Beijing tertiary hospital and compared pr...

Clinical Trials [13 Associated Clinical Trials listed on BioPortfolio]

Improvement of Ambulance Response Times in Karachi, Pakistan

The investigators hypothesize that spatial analysis of the location data of ambulance calls can improve prehospital care provided by Aman Foundation in Karachi, Pakistan by decreasing ambu...

Comparing Different Methods of Patient Education on Preeclampsia

Preeclampsia is a life-threatening condition unique to pregnancy which occurs in 5-8% of all pregnancies. It contributes to a large proportion of maternal mortality worldwide and these dea...

A Feasibility (Pilot) Study of an Innovative Non-pharmacological Intervention Program in at Risk Youth

At risk youth face various adversities including homelessness, social isolation, substance abuse and other mental illnesses. Thus far, the investigators have successfully partnered on prog...

Defining a PD-specific Breath Fingerprint of Underlying Inflammatory and Neurodegenerative Processes

The purpose of this study is to determine the potential for a Parkinson's Disease (PD) -specific breath signature as a non-invasive screening tool for identifying PD patients with inflamma...

Population Pharmacokinetics of Cephalosporins and Macrolides in Chinese Children With Community Acquired Pneumonia

This study is based on the hypothesis that the pharmacokinetics of antibiotics in children is different from adults. Cephalosporins and macrolide antibiotics are the common drugs for child...

Companies [1 Associated Companies listed on BioPortfolio]

Inamori Foundation

The non-profit Inamori Foundation was established in 1984 by Dr. Kazuo Inamori, founder and chairman emeritus of Kyocera (NYSE:KYO) and KDDI Corporation. The Foundation created th...

More Information about "Inamori Foundation" on BioPortfolio

We have published hundreds of Inamori Foundation news stories on BioPortfolio along with dozens of Inamori Foundation Clinical Trials and PubMed Articles about Inamori Foundation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Inamori Foundation Companies in our database. You can also find out about relevant Inamori Foundation Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record